← Oncology Approval Tracker

FDA DECISION ·

Keytruda

pembrolizumab · Merck

Traditional approvalTraditional conversionMerkel cell carcinoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

For adults and children with recurrent locally advanced or metastatic Merkel cell carcinoma.

LAMPGEN ANALYSIS

Why it matters

The action converted the earlier accelerated Merkel cell carcinoma indication to traditional approval.

What research teams should watch

Maintain the conversion date separately from the initial approval and record the recurrent or metastatic setting.

PRIMARY RECORDS

Sources